Introduction
Chronic spontaneous urticaria (CSU) can cause ongoing hives and itching that may continue even when patients are taking H1-antihistamines. Rhapsido (remibrutinib) is a prescription medication approved for adults with CSU who remain symptomatic despite H1-antihistamine treatment.
Rhapsido is an oral BTK inhibitor that targets a specific immune-system pathway involved in the immune processes associated with CSU. By targeting this pathway, Rhapsido may help reduce hives and itching in appropriate patients. In clinical studies, Rhapsido produced greater improvements in itch and hive severity than placebo.
Prescription medications can also create financial challenges for patients and families. Prescription Hope may help eligible patients navigate available prescription assistance programs and explore whether assistance may be available based on their individual circumstances and program requirements.
What Is the Rhapsido Patient Assistance Program?
The retail costs of medication are on the rise. And unfortunately, patients across America are struggling to afford their brand-name medications.
To help alleviate this struggle, manufacturers often offer a solution: patient assistance programs.
Through these programs, such as the Rhapsido patient assistance program, qualified patients get access to their brand-name medication at an affordable rate.
Unfortunately, patient assistance programs have a reputation for being difficult to apply for. They can leave patients feeling frustrated and overwhelmed. In fact, some patients give up on their medication altogether, deciding they cannot afford to fill their prescription.
How Expert Advocates Help Make Rhapsido More Affordable
Personalized Medication Assistance
It can be tough to find medication affordability help. While plenty of programs exist that help with financial assistance for Rhapsido and other brand-name medications, getting through the application and approval process can be difficult.
Prescription Hope offers application support services as well as ongoing patient advocacy. Our team manages the application process from start to finish. We complete forms, collect documents, gather signatures from healthcare providers, coordinate with the manufacturers, and more.
Ongoing Patient Support
After a patient receives approval, we continue to handle the administrative tasks associated with continued enrollment.
Our team takes care of refill scheduling, updates documents and necessary information, provides issue resolution, manages yearly renewals, and more.
Rhapsido Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Navigating Treatment Costs
Rhapsido Patient Assistance Eligibility
Those interested in learning more about the Rhapsido assistance requirements should enroll with Prescription Hope to find out more.
All programs maintain strict qualification requirements in certain general categories. Some of those include:
Income: While an income range is used for all programs, each one varies in the specific income range acceptable for qualification.
Insurance: Programs’ insurance coverage status requirements vary. Some programs require a qualified patient to have no insurance. Other programs may allow for some form of coverage.
Prescription: Qualified patients must have a valid prescription for their program’s medication.
Residency: All patients must be legal US residents to qualify.
Simple Enrollment With Expert Support
Submit Your Information
Here’s how to get started with your enrollment process through Prescription Hope:
- Submit Information: Take a few minutes to submit your online enrollment form.
- Advocate Contact: Once we receive your form, a patient advocate will contact you within 1-2 business days.
- Document Collection: After prequalification, our team will collect all necessary documents.
- Provider Coordination: We also coordinate with your healthcare provider to secure needed signatures.
- Application Submission: Once everything is in order, we submit your application and continue to coordinate with the manufacturer throughout the processing stage.
- Medication Delivery: After approval, patients typically receive their medication within 2 weeks. All medications ship directly from the manufacturer to the patient’s house or doctor’s office.
Prescription Hope is not a manufacturer or pharmacy, and does not handle medication at any time.
Understanding Rhapsido Important Safety Information and Side Effects
Rhapsido can cause side effects and has important safety considerations. Patients should discuss questions about treatment, side effects, medical history, and other medications with their healthcare provider.
The most common adverse reactions, occurring in 3% or more of patients, include nasopharyngitis, bleeding, headache, nausea, and abdominal pain.
Risk of Bleeding
Rhapsido can increase the risk of bleeding. In clinical studies, mucocutaneous-related bleeding occurred in 9% of patients who received Rhapsido. Treatment should be interrupted if bleeding occurs and may be resumed if the expected benefit of treatment outweighs the risk.
The risk of bleeding may increase when Rhapsido is used with antithrombotic medications. Healthcare providers should consider the benefits and risks of using antithrombotic therapy at the same time and monitor for signs and symptoms of bleeding.
Surgery and Invasive Procedures
Because of the potential risk of bleeding, Rhapsido should be temporarily interrupted for 3 to 7 days before and after surgery or an invasive procedure, depending on the procedure and the patient’s bleeding risk.
Vaccines
Live or live-attenuated vaccines should be avoided during treatment with Rhapsido.
Pregnancy and Breastfeeding
Available human data are insufficient to establish a drug-associated risk during pregnancy. Based on animal studies, Rhapsido may cause fetal harm. Females of reproductive potential should use effective contraception during treatment and for 1 week after the last dose.
There are no data on the presence of remibrutinib in human milk, its effects on a breastfed child, or its effects on milk production. Because of the potential for serious adverse reactions, patients should not breastfeed during treatment and for 1 week after the last dose.
Drug Interactions
Rhapsido can interact with other medications. Patients should provide their healthcare provider with a complete list of prescription medications, over-the-counter medications, vitamins, and supplements.
Strong or moderate CYP3A4 inhibitors can increase remibrutinib exposure and may increase the risk of adverse reactions. Strong or moderate CYP3A4 inducers can decrease remibrutinib exposure and may reduce the effectiveness of Rhapsido. Concomitant use with either strong or moderate CYP3A4 inhibitors or inducers should be avoided.
Remibrutinib can also increase exposure to certain P-glycoprotein (P-gp) substrates. Patients taking P-gp substrates for which even small increases in drug concentrations may cause serious adverse reactions may require more frequent monitoring. Digoxin is one example identified in the prescribing information.
Using Rhapsido with antithrombotic medications may increase the risk of bleeding.
Administration and Other Important Considerations
Rhapsido is taken orally twice daily, with or without food. The recommended dosage is 25 mg twice daily.
The tablets should be swallowed whole and should not be split, crushed, or chewed.
This medication should be avoided in patients with mild, moderate, or severe hepatic impairment.
The current FDA-approved labeling lists no contraindications, and Rhapsido does not carry an FDA Boxed Warning.
This medication is specifically approved for adults with chronic spontaneous urticaria who remain symptomatic despite H1-antihistamine treatment. It is not indicated for other forms of urticaria.
Access to Multiple Medications
While prescription medication cost assistance can transform your life, the costs of other brand-name medications can quickly make you feel like nothing has changed.
We offer a list of hundreds of available medications for access. Thankfully, many patients find they can save not just on their primary brand-name medication, but for other medications as well.
And all of our services are included for $70.00 per month, per medication, no matter how many medications you qualify for.
Why Choose Prescription Hope for Rhapsido Assistance
Patient-Focused Medication Support
Getting assistance for medication costs can be a complex and drawn-out process. But with Prescription Hope, patients get our team of dedicated patient advocates working for them throughout the application process.
For 20 years, hundreds of thousands of Americans have trusted Prescription Hope.
Simplified Access to Specialty Therapies
For $70.00 per month, per medication, qualified patients get access to Rhapsido, as well as our expert staff’s support and patient-advocacy services.
Plus, our patients are never charged add-ons, hidden fees, or medication costs.
Ongoing Prescription Assistance
Why choose Prescription Hope for your Rhapsido financial assistance support? Prescription Hope doesn’t just help you with the application. Our team of patient advocates works for you throughout your medication journey with us. We handle the tasks necessary to keep your qualification. This means things like refill scheduling, document updates, information updates, issue resolution, yearly renewals, and more.
Those interested in getting access to their Rhapsido for $70.00 per month, per medication should enroll with Prescription Hope today.